NCT03032484 TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma Status COMPLETED Phase PHASE2
NCT02976441 Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas Status WITHDRAWN Phase EARLY_PHASE1
NCT02942264 Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT02764151 First in Patient Study for PF-06840003 in Malignant Gliomas Status TERMINATED Phase PHASE1
NCT02747407 Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors Status COMPLETED Phase N/A
NCT02684058 Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors Status COMPLETED Phase PHASE2
NCT02372409 Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors Status TERMINATED Phase PHASE2
NCT02209428 A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas Status UNKNOWN Phase PHASE2
NCT02010606 Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT01849952 Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas Status TERMINATED Phase N/A
NCT01649830 Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma Status RECRUITING Phase PHASE3
NCT01579253 Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients Status UNKNOWN Phase N/A
NCT01502605 Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas Status TERMINATED Phase PHASE1
NCT01351519 A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors Status TERMINATED Phase PHASE2
NCT01288235 Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation Status COMPLETED Phase PHASE2
NCT01125800 A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB Status COMPLETED Phase PHASE1/PHASE2